Fulcrum Therapeutics' promising treatment for Sickle Cell Disease and their strong financial position, despite setbacks.

Learn more about whether QuidelOrtho Corporation or DENTSPLY SIRONA Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Learn more about whether Haemonetics Corporation or LeMaitre Vascular, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

JMP Securities reiterated its Market Outperform rating on Protagonist Therapeutics (NASDAQ:PTGX) with a steady price target ...

We recently published a list of 10 Firms Hit Hard in Thursday’s Trading. In this article, we are going to take a look at ...

Congressional stock trading has been a contentious issue in Washington, with Sen. Jon Ossoff proposing legislation to ban it, ...

We recently compiled a list of the 12 Trending AI Stocks on Latest News and Ratings. In this article, we are going to take a look at where Inspira Technologies Oxy B.H.N. Ltd.

Lower construction spending on data centers because of DeepSeek could negatively impact heavy equipment stocks like ...

The company also issued a 2025 guidance that fell short of expectations, as some of the company’s older drugs face ...

The volatile start to the year has spooked some professional investors but has done little to dowse retail traders’ ...

Retail investors are pushing their weight around in 2025, and buying stocks like Nvidia and Tesla on dips, says Goldman Sachs ...

Legendary short seller Jim Chanos says no one can see the biggest risks facing US markets over the next six to 12 months — ...